Chemogenics biopharma, LLC:1210198 [22-002005]

Ended Purchase Order Awarded Last action

Contract number
75N95022P00152
Awardee
Awarding agency
Obligated
$249,500

Award facts

Opportunity
Contract value 100% obligated
$249,500.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27707, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $249,500

About this award

This is a $249,500 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Chemogenics Biopharma, LLC, a small business. The contract is for synthesis and bioanalytical analysis support services related to the therapeutic areas of the microbiome, neurodegeneration, and addiction. The services will augment existing medicinal chemistry campaigns within the National Center for Advancing Translational Sciences (NCATS). The period of performance is 12 months from the March 2022 award date.

Quick answers

Who was awarded contract 75N95022P00152?

75N95022P00152 was awarded to Chemogenics Biopharma, LLC by National Institute on Drug Abuse (National Institutes of Health) on March 11, 2022.

How much is contract 75N95022P00152 worth?

The government has obligated $249,500 on 75N95022P00152.

Was contract 75N95022P00152 competed?

The extent of competition for 75N95022P00152 was competed under sap. The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award